Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders

Alessandra Fragale, Marco Tartaglia, Silvia Bernardini, A. M Michela Di Stasi, Concezio Di Rocco, Francesco Velardi, Anna Teti, Piero A. Battaglia, Silvia Migliaccio

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Craniosynostoses are a heterogeneous group of disorders characterized by premature fusion of cranial sutures. Mutations in fibroblast growth factor receptors (FGFRs) have been associated with a number of such conditions. Nevertheless, the cellular mechanism(s) involved remain unknown. We analyzed cell proliferation and differentiation in osteoblasts obtained from patients with three genetically and clinically distinct craniosynostoses: Pfeiffer syndrome carrying the FGFR2 C342R substitution, Apert syndrome with FGFR2 P253R change, and a nonsyndromic craniosynostosis without FGFR canonic mutations, as compared with control osteoblasts. Osteoblasts from craniosynostotic patients exhibited a lower proliferation rate than control osteoblasts. P253R and nonsyndromic craniosynostosis osteoblasts showed a marked differentiated phenotype, characterized by high alkaline phosphatase activity, increased mineralization and expression of noncollagenous matrix proteins, associated with high expression and activation of protein kinase Cα and protein kinase Cε isoenzymes. By contrast, the low proliferation rate of C342R osteoblasts was not associated with a differentiated phenotype. Although they showed higher alkaline phosphatase activity than control, C342R osteoblasts failed to mineralize and expressed low levels of osteopontin and osteonectin and high protein kinase Cζ levels. Stimulation of proliferation and inhibition of differentiation were observed in all cultures on FGF2 treatment. Our results suggest that an anticipated proliferative/differentiative switch, associated with alterations of the FGFR transduction pathways, could be the causative com mon feature in craniosynostosis and that mutations in distinct FGFR2 domains are associated with an in vitro heterogeneous differentiative phenotype.

Original languageEnglish
Pages (from-to)1465-1477
Number of pages13
JournalAmerican Journal of Pathology
Volume154
Issue number5
Publication statusPublished - May 1999

Fingerprint

Osteoblasts
Craniosynostoses
Fibroblast Growth Factor Receptors
Acrocephalosyndactylia
Phenotype
Protein Kinase C
Mutation
Alkaline Phosphatase
Cranial Sutures
Osteonectin
Osteopontin
Fibroblast Growth Factor 2
Isoenzymes
Cell Differentiation
Cell Proliferation
Proteins

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Fragale, A., Tartaglia, M., Bernardini, S., Di Stasi, A. M. M., Di Rocco, C., Velardi, F., ... Migliaccio, S. (1999). Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders. American Journal of Pathology, 154(5), 1465-1477.

Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders. / Fragale, Alessandra; Tartaglia, Marco; Bernardini, Silvia; Di Stasi, A. M Michela; Di Rocco, Concezio; Velardi, Francesco; Teti, Anna; Battaglia, Piero A.; Migliaccio, Silvia.

In: American Journal of Pathology, Vol. 154, No. 5, 05.1999, p. 1465-1477.

Research output: Contribution to journalArticle

Fragale, A, Tartaglia, M, Bernardini, S, Di Stasi, AMM, Di Rocco, C, Velardi, F, Teti, A, Battaglia, PA & Migliaccio, S 1999, 'Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders', American Journal of Pathology, vol. 154, no. 5, pp. 1465-1477.
Fragale, Alessandra ; Tartaglia, Marco ; Bernardini, Silvia ; Di Stasi, A. M Michela ; Di Rocco, Concezio ; Velardi, Francesco ; Teti, Anna ; Battaglia, Piero A. ; Migliaccio, Silvia. / Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders. In: American Journal of Pathology. 1999 ; Vol. 154, No. 5. pp. 1465-1477.
@article{9f4ff26673db4eeb9cd12d72d22b3a79,
title = "Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders",
abstract = "Craniosynostoses are a heterogeneous group of disorders characterized by premature fusion of cranial sutures. Mutations in fibroblast growth factor receptors (FGFRs) have been associated with a number of such conditions. Nevertheless, the cellular mechanism(s) involved remain unknown. We analyzed cell proliferation and differentiation in osteoblasts obtained from patients with three genetically and clinically distinct craniosynostoses: Pfeiffer syndrome carrying the FGFR2 C342R substitution, Apert syndrome with FGFR2 P253R change, and a nonsyndromic craniosynostosis without FGFR canonic mutations, as compared with control osteoblasts. Osteoblasts from craniosynostotic patients exhibited a lower proliferation rate than control osteoblasts. P253R and nonsyndromic craniosynostosis osteoblasts showed a marked differentiated phenotype, characterized by high alkaline phosphatase activity, increased mineralization and expression of noncollagenous matrix proteins, associated with high expression and activation of protein kinase Cα and protein kinase Cε isoenzymes. By contrast, the low proliferation rate of C342R osteoblasts was not associated with a differentiated phenotype. Although they showed higher alkaline phosphatase activity than control, C342R osteoblasts failed to mineralize and expressed low levels of osteopontin and osteonectin and high protein kinase Cζ levels. Stimulation of proliferation and inhibition of differentiation were observed in all cultures on FGF2 treatment. Our results suggest that an anticipated proliferative/differentiative switch, associated with alterations of the FGFR transduction pathways, could be the causative com mon feature in craniosynostosis and that mutations in distinct FGFR2 domains are associated with an in vitro heterogeneous differentiative phenotype.",
author = "Alessandra Fragale and Marco Tartaglia and Silvia Bernardini and {Di Stasi}, {A. M Michela} and {Di Rocco}, Concezio and Francesco Velardi and Anna Teti and Battaglia, {Piero A.} and Silvia Migliaccio",
year = "1999",
month = "5",
language = "English",
volume = "154",
pages = "1465--1477",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders

AU - Fragale, Alessandra

AU - Tartaglia, Marco

AU - Bernardini, Silvia

AU - Di Stasi, A. M Michela

AU - Di Rocco, Concezio

AU - Velardi, Francesco

AU - Teti, Anna

AU - Battaglia, Piero A.

AU - Migliaccio, Silvia

PY - 1999/5

Y1 - 1999/5

N2 - Craniosynostoses are a heterogeneous group of disorders characterized by premature fusion of cranial sutures. Mutations in fibroblast growth factor receptors (FGFRs) have been associated with a number of such conditions. Nevertheless, the cellular mechanism(s) involved remain unknown. We analyzed cell proliferation and differentiation in osteoblasts obtained from patients with three genetically and clinically distinct craniosynostoses: Pfeiffer syndrome carrying the FGFR2 C342R substitution, Apert syndrome with FGFR2 P253R change, and a nonsyndromic craniosynostosis without FGFR canonic mutations, as compared with control osteoblasts. Osteoblasts from craniosynostotic patients exhibited a lower proliferation rate than control osteoblasts. P253R and nonsyndromic craniosynostosis osteoblasts showed a marked differentiated phenotype, characterized by high alkaline phosphatase activity, increased mineralization and expression of noncollagenous matrix proteins, associated with high expression and activation of protein kinase Cα and protein kinase Cε isoenzymes. By contrast, the low proliferation rate of C342R osteoblasts was not associated with a differentiated phenotype. Although they showed higher alkaline phosphatase activity than control, C342R osteoblasts failed to mineralize and expressed low levels of osteopontin and osteonectin and high protein kinase Cζ levels. Stimulation of proliferation and inhibition of differentiation were observed in all cultures on FGF2 treatment. Our results suggest that an anticipated proliferative/differentiative switch, associated with alterations of the FGFR transduction pathways, could be the causative com mon feature in craniosynostosis and that mutations in distinct FGFR2 domains are associated with an in vitro heterogeneous differentiative phenotype.

AB - Craniosynostoses are a heterogeneous group of disorders characterized by premature fusion of cranial sutures. Mutations in fibroblast growth factor receptors (FGFRs) have been associated with a number of such conditions. Nevertheless, the cellular mechanism(s) involved remain unknown. We analyzed cell proliferation and differentiation in osteoblasts obtained from patients with three genetically and clinically distinct craniosynostoses: Pfeiffer syndrome carrying the FGFR2 C342R substitution, Apert syndrome with FGFR2 P253R change, and a nonsyndromic craniosynostosis without FGFR canonic mutations, as compared with control osteoblasts. Osteoblasts from craniosynostotic patients exhibited a lower proliferation rate than control osteoblasts. P253R and nonsyndromic craniosynostosis osteoblasts showed a marked differentiated phenotype, characterized by high alkaline phosphatase activity, increased mineralization and expression of noncollagenous matrix proteins, associated with high expression and activation of protein kinase Cα and protein kinase Cε isoenzymes. By contrast, the low proliferation rate of C342R osteoblasts was not associated with a differentiated phenotype. Although they showed higher alkaline phosphatase activity than control, C342R osteoblasts failed to mineralize and expressed low levels of osteopontin and osteonectin and high protein kinase Cζ levels. Stimulation of proliferation and inhibition of differentiation were observed in all cultures on FGF2 treatment. Our results suggest that an anticipated proliferative/differentiative switch, associated with alterations of the FGFR transduction pathways, could be the causative com mon feature in craniosynostosis and that mutations in distinct FGFR2 domains are associated with an in vitro heterogeneous differentiative phenotype.

UR - http://www.scopus.com/inward/record.url?scp=0032934535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032934535&partnerID=8YFLogxK

M3 - Article

C2 - 10329600

AN - SCOPUS:0032934535

VL - 154

SP - 1465

EP - 1477

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 5

ER -